West Pharmaceutical Services
Stock Forecast, Prediction & Price Target
West Pharmaceutical Services (WST) stock Price Target by analysts
$393
Potential upside: 59.12%
West Pharmaceutical Services price prediction
What is West Pharmaceutical Services stock analysts` prediction?
West Pharmaceutical Services stock forecast: Based on 1 Wall Street analysts` predicted price targets for West Pharmaceutical Services in the last 3 months, the avarage price target is $393, with a high forecast of $NaN. The average price target represents a 59.12% change from the last price of $246.98.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
West Pharmaceutical Services stock Price Target by analysts
Full breakdown of analysts given West Pharmaceutical Services price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Windley Jefferies | 0% 0/2 | 10 months ago | $393 59.12% upside | $287.85 | StreetInsider | Previous targets (1) |
David Windley Jefferies | 0% 0/2 | over 1 year ago | $536 117.02% upside | $413 | StreetInsider | Previous targets (1) |
Unknown Deutsche Bank | N/A | almost 3 years ago | $250 1.22% upside | $251.9 | Benzinga | N/A |
Unknown UBS | N/A | almost 3 years ago | $250 1.22% upside | $222.84 | Benzinga | N/A |
West Pharmaceutical Services Financial Estimates
West Pharmaceutical Services Revenue Estimates
West Pharmaceutical Services EBITDA Estimates
West Pharmaceutical Services Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $2.83B N/A | $2.88B 1.95% | $2.94B 2.17% | Avg: $3.27B Low: $3.25B High: $3.30B avg. 11.14% | Avg: $3.53B Low: $3.51B High: $3.55B avg. 7.69% | ||
Net Income
% change YoY
| $661.8M N/A | $585.9M -11.46% | $593.4M 1.28% | Avg: $667.55M Low: $625.60M High: $710.07M avg. 12.49% | Avg: $750.35M Low: $706.21M High: $761.28M avg. 12.40% | ||
EBITDA
% change YoY
| $878.4M N/A | $854.6M -2.70% | $844.1M -1.22% | Avg: $892.68M Low: $887.22M High: $900.87M avg. 5.75% | Avg: $961.42M Low: $955.78M High: $968.97M avg. 7.69% | ||
EPS
% change YoY
| $8.9 N/A | $7.88 -11.46% | $7.99 1.39% | Avg: $8.86 Low: $8.31 High: $9.43 avg. 10.90% | Avg: $9.81 Low: $9.38 High: $10.11 avg. 10.75% | ||
Operating Expenses
% change YoY
| $423.5M N/A | $402.2M -5.02% | $454M 12.87% | Avg: $423.98M Low: $421.39M High: $427.87M avg. -6.61% | Avg: $456.63M Low: $453.95M High: $460.22M avg. 7.69% | ||
FAQ
What is West Pharmaceutical Services stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 12.44% in 2025-2026.
We have gathered data from 6 analysts. Their low estimate is 625.60M, average is 667.55M and high is 710.07M.
What is West Pharmaceutical Services stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.42% in 2025-2026.
We have gathered data from 7 analysts. Their low revenue estimate is $3.25B, average is $3.27B and high is $3.30B.
What is West Pharmaceutical Services stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 10.83% in 2025-2026.
We have gathered data from 6 analysts. Their low earnings per share estimate is $8.31, average is $8.86 and high is $9.43.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering West Pharmaceutical Services stock. The most successful analyst is David Windley.